TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34606988

Group type: EXPERIMENTAL
Intervention: Telehealth counseling duration (4 weeks vs. 8 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy duration (2 weeks vs. 8 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systematic screening and referral for social determinants of health via 'AuntBertha' (referral)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No referral for social determinants of health
Number of subjects: 0
Study: 33321698

Group type: EXPERIMENTAL
Intervention: Bidirectional gated recurrent unit model
Number of subjects: 10

Group type: COMPARATOR
Intervention: Traditional gated recurrent unit model
Number of subjects: 10
Study: 35851368

Group type: EXPERIMENTAL
Intervention: Closure of the platysma muscle layer
Number of subjects: 92

Group type: COMPARATOR
Intervention: Non-closure of the platysma muscle layer
Number of subjects: 92
Study: 34774197

Group type: EXPERIMENTAL
Intervention: ChAdOx1 plus cellular quadrivalent influenza vaccine
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: BNT162b2 plus cellular quadrivalent influenza vaccine
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: BNT162b2 plus MF59C adjuvanted, trivalent influenza vaccine
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: ChAdOx1 plus recombinant quadrivalent influenza vaccine
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: ChAdOx1 plus MF59C adjuvanted, trivalent influenza vaccine
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: BNT162b2 plus recombinant quadrivalent influenza vaccine
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: Concomitant administration of COVID-19 and influenza vaccines
Number of subjects: 679

Group type: EXPERIMENTAL
Intervention: Concomitant vaccination with ChAdOx1 or BNT162b2 plus an age-appropriate influenza vaccine
Number of subjects: 679
Study: 33491390

Group type: EXPERIMENTAL
Intervention: BIA with the aid of DentalVibe
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional BIA
Number of subjects: 60
Study: 35963295

Group type: EXPERIMENTAL
Intervention: Exergame training
Number of subjects: 52

Group type: COMPARATOR
Intervention: Motor-cognitive dual-task training
Number of subjects: 52
Study: 33938672

Group type: EXPERIMENTAL
Intervention: CI-based hemodynamic management
Number of subjects: 60

Group type: COMPARATOR
Intervention: MAP-based hemodynamic management
Number of subjects: 60
Study: 32820000

Group type: EXPERIMENTAL
Intervention: Leucocyte-rich PRP (LR-PRP) injection
Number of subjects: 68

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 68
Study: 35704219

Group type: EXPERIMENTAL
Intervention: Gluma
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sodium fluoride varnish (5%)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser (wavelength 2780 nm, frequency 20 Hz, power 0.25 W, energy density 44.3 J/cm2, pulse width of 150 µs for 30 s)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Gluma + Er,Cr:YSGG laser
Number of subjects: 55

Group type: COMPARATOR
Intervention: Sodium fluoride varnish + Gluma
Number of subjects: 55
Study: 34024809

Group type: EXPERIMENTAL
Intervention: Nomogram combining radiomics signature and clinical features
Number of subjects: 300

Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 300

Group type: COMPARATOR
Intervention: Radiomics signature model
Number of subjects: 300
Study: 33135590

Group type: EXPERIMENTAL
Intervention: Mindfulness activity (body scan)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 144
Study: 32089371

Group type: COMPARATOR
Intervention: High intensity interval training plus whole-body electromyostimulation (HIIT + EMS)
Number of subjects: 71

Group type: COMPARATOR
Intervention: High intensity interval training (HIIT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Concurrent training based on international physical activity recommendations (PAR group)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: No exercise (Control group)
Number of subjects: 71
Study: 34621519

Group type: EXPERIMENTAL
Intervention: Vancomycin IV plus ascorbic acid (n=21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Vancomycin IV only (n=20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (vancomycin IV only)
Number of subjects: 41
Study: 32158190

Group type: EXPERIMENTAL
Intervention: Fimasartan 120 mg
Number of subjects: 365

Group type: COMPARATOR
Intervention: Valsartan 160 mg
Number of subjects: 365
Study: 35297659

Group type: EXPERIMENTAL
Intervention: LT3 treatment (0.8 μg/kg i.v. bolus followed by 0.113 μg/kg/h i.v. infusion for 48 hours)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: LT3 treatment
Number of subjects: 37
Study: 33544916

Group type: EXPERIMENTAL
Intervention: Educational workshop on incontinence
Number of subjects: 392
Study: 33796965

Group type: EXPERIMENTAL
Intervention: Compound topical anesthetic (CTA) combined with photobiomodulation therapy (PBMT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Local anesthesia with 2% lidocaine hydrochloride
Number of subjects: 25
Study: 32729014

Group type: EXPERIMENTAL
Intervention: Entecavir (ETV) 0.5 mg/day
Number of subjects: 120

Group type: COMPARATOR
Intervention: Tenofovir Disoproxil Fumarate (TDF) 245 mg/day
Number of subjects: 120
Study: 35504256

Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 14

Group type: COMPARATOR
Intervention: SiPAP
Number of subjects: 14
Study: 32151227

Group type: EXPERIMENTAL
Intervention: Inorganic nitrate drink (140-ml beetroot juice per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 34608614

Group type: EXPERIMENTAL
Intervention: Intervention developed to promote psychological and academic well-being
Number of subjects: 15

Group type: COMPARATOR
Intervention: Business as usual (Control)
Number of subjects: 15
Study: 34972894

Group type: EXPERIMENTAL
Intervention: Pythagorean Self‐Awareness Intervention (PSAI) for 8 weeks along with continuous positive airway pressure (CPAP) treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP) treatment alone
Number of subjects: 30
Study: 35700338

Group type: EXPERIMENTAL
Intervention: CCTA-defined extent and stenosis severity of CAD based on the modified Duke Prognostic Index
Number of subjects: 2475
Study: 34370911

Group type: EXPERIMENTAL
Intervention: Flavored, non‐fluoridated, alcohol‐free mouthwash containing 0.1% chlorine dioxide
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 35743790

Group type: EXPERIMENTAL
Intervention: Psychotherapy plus escitalopram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychotherapy plus placebo
Number of subjects: 0
Study: 33319386

Group type: EXPERIMENTAL
Intervention: Chronic Disease Self-Management Program (CDSMP) combined with interactive technology-enhanced coaching
Number of subjects: 90

Group type: COMPARATOR
Intervention: Chronic Disease Self-Management Program (CDSMP) alone
Number of subjects: 90
Study: 34146117

Group type: EXPERIMENTAL
Intervention: mono-J insertion for 6 hours after ureterorenoscopy
Number of subjects: 108

Group type: COMPARATOR
Intervention: double-J insertion for 3-5 days after ureterorenoscopy
Number of subjects: 108
Study: 35143453

Group type: EXPERIMENTAL
Intervention: Ergonomic intervention (20-week program with three workshops)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 190
Study: 32795144

Group type: EXPERIMENTAL
Intervention: Top commercially available diabetes apps
Number of subjects: 92
Study: 35143219

Group type: EXPERIMENTAL
Intervention: Intensive EMDR
Number of subjects: 96

Group type: COMPARATOR
Intervention: Intensive PC
Number of subjects: 96
Study: 33674871

Group type: EXPERIMENTAL
Intervention: IA (Ivermectin plus Albendazole)
Number of subjects: 144

Group type: COMPARATOR
Intervention: ALB 400 mg
Number of subjects: 144

Group type: COMPARATOR
Intervention: ALB 800 mg
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: IA
Number of subjects: 144
Study: 32133668

Group type: EXPERIMENTAL
Intervention: Home visit by occupational therapist
Number of subjects: 65

Group type: COMPARATOR
Intervention: Usual care (hospital-based assessment)
Number of subjects: 65
Study: 34384941

Group type: EXPERIMENTAL
Intervention: Inertial flywheel resistance training (N = 21)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Heavy slow resistance training (N = 21)
Number of subjects: 42
Study: 33065663

Group type: EXPERIMENTAL
Intervention: Taylor Spatial Frame (TSF)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Reamed Intramedullary Nail (IMN)
Number of subjects: 63
Study: 35620986

Group type: COMPARATOR
Intervention: Saline hydration alone (n=81)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Oral bicarbonate (n=78)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Intravenous bicarbonate (n=82)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Patients achieving a pH >6 before angiography (n=145)
Number of subjects: 241
Study: 34033648

Group type: EXPERIMENTAL
Intervention: Dexamethasone 6 mg QD for 7 to 10 days
Number of subjects: 216

Group type: COMPARATOR
Intervention: Methylprednisolone 250 to 500 mg daily for 3 days followed by oral prednisone 50 mg daily for 14 days
Number of subjects: 216
Study: 32517490

Group type: EXPERIMENTAL
Intervention: Baduanjin training (24 weeks, 3 days a week, 40 minutes per session)
Number of subjects: 48
Study: 34097649

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Technique (EFT)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 162
Study: 33652088

Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation (cTBS) over the left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation (cTBS) over the right hemisphere
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 49
Study: 32780705

Group type: EXPERIMENTAL
Intervention: DCOT-LS-SVMs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IDCOT-LS-SVMs
Number of subjects: 0
Study: 32331053

Group type: EXPERIMENTAL
Intervention: Lurasidone monotherapy
Number of subjects: 1192

Group type: EXPERIMENTAL
Intervention: Lurasidone adjunctive therapy
Number of subjects: 1192

Group type: COMPARATOR
Intervention: Placebo (short-term)
Number of subjects: 1192

Group type: COMPARATOR
Intervention: Placebo (adjunctive therapy)
Number of subjects: 1192

Group type: EXPERIMENTAL
Intervention: Adjunctive lurasidone (recurrence prevention study)
Number of subjects: 1192

Group type: COMPARATOR
Intervention: Adjunctive placebo (recurrence prevention study)
Number of subjects: 1192
Study: 34048941

Group type: EXPERIMENTAL
Intervention: Induction of labour (IOL)
Number of subjects: 38
Study: 35685535

Group type: EXPERIMENTAL
Intervention: Sesame Oil (SO), 30 grams per day for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sunflower Oil (SFO), 30 grams per day for 12 weeks
Number of subjects: 60
Study: 34168425

Group type: EXPERIMENTAL
Intervention: Cold intraoperative irrigating solution (2.7±0.1°C)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Room temperature irrigating solution (20.0±0.1°C)
Number of subjects: 100
Study: 36402700

Group type: EXPERIMENTAL
Intervention: Daratumumab, Bortezomib, and Dexamethasone (D-Vd)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Bortezomib and Dexamethasone (Vd)
Number of subjects: 211
Study: 33881605

Group type: EXPERIMENTAL
Intervention: Laser treatment followed by skin surface application of a cosmeceutical containing growth factors (GFs) and Vitamin C
Number of subjects: 132

Group type: COMPARATOR
Intervention: Laser resurfacing followed by skin surface application of Vitamin C
Number of subjects: 132
Study: 32471651

Group type: EXPERIMENTAL
Intervention: Studies that declared funding and adherence to CONSORT
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Overall randomised controlled trials in oral and maxillofacial surgery
Number of subjects: 303
Study: 35964661

Group type: EXPERIMENTAL
Intervention: Delivery room insertion of etonogestrel contraceptive implant (0-2 hours post-delivery)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Delayed insertion of etonogestrel contraceptive implant (24-48 hours post-delivery)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Delivery room insertion of etonogestrel contraceptive implant
Number of subjects: 95

Group type: COMPARATOR
Intervention: Delayed insertion of etonogestrel contraceptive implant
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups (delivery room and delayed insertion)
Number of subjects: 95
Study: 34726708

Group type: EXPERIMENTAL
Intervention: Lower-dose amoxicillin (35-50 mg/kg/d)
Number of subjects: 824

Group type: COMPARATOR
Intervention: Higher-dose amoxicillin (70-90 mg/kg/d)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: 3-day treatment
Number of subjects: 824

Group type: COMPARATOR
Intervention: 7-day treatment
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Lower-dose amoxicillin in severe CAP
Number of subjects: 824

Group type: COMPARATOR
Intervention: Higher-dose amoxicillin in severe CAP
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: 3-day treatment in severe CAP
Number of subjects: 824

Group type: COMPARATOR
Intervention: 7-day treatment in severe CAP
Number of subjects: 824
Study: 35381377

Group type: EXPERIMENTAL
Intervention: Weekly shipments of five breakfast and lunch meals that mimic school meals
Number of subjects: 100

Group type: COMPARATOR
Intervention: Weekly newsletter on community resources
Number of subjects: 100
Study: 34506689

Group type: EXPERIMENTAL
Intervention: High-flow nasal cannula therapy (HFNC)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard low flow nasal oxygen via nasal prongs (NC)
Number of subjects: 104
Study: 32932394

Group type: EXPERIMENTAL
Intervention: Scleral lens wear for 4 hours
Number of subjects: 20
Study: 35488406

Group type: EXPERIMENTAL
Intervention: Behaviour change interventions
Number of subjects: 5175

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 5175
Study: 32143062

Group type: EXPERIMENTAL
Intervention: Perceptually dissimilar condition with similar semantic objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perceptually similar condition with similar semantic objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantically dissimilar condition with similar perceptual objects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantically similar condition with similar perceptual objects
Number of subjects: 0
Study: 35895295

Group type: EXPERIMENTAL
Intervention: OVD group (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: OVD-free group (n = 30)
Number of subjects: 60
Study: 33048561

Group type: EXPERIMENTAL
Intervention: BA + PAD
Number of subjects: 40

Group type: COMPARATOR
Intervention: PAD-only
Number of subjects: 40
Study: 33058123

Group type: EXPERIMENTAL
Intervention: Perceived strong family support
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Diagnosis of disease for more than 10 years
Number of subjects: 390

Group type: COMPARATOR
Intervention: General population
Number of subjects: 390
Study: 35683982

Group type: EXPERIMENTAL
Intervention: PKU Bite® app
Number of subjects: 81

Group type: COMPARATOR
Intervention: Written/pictorial material (control)
Number of subjects: 81
Study: 34265055

Group type: EXPERIMENTAL
Intervention: Sucrose-sweetened beverage (SB)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: HFCS-sweetened beverage (SB)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Aspartame-sweetened beverage (SB)
Number of subjects: 75
Study: 35089373

Group type: EXPERIMENTAL
Intervention: BI 409306 50 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BI 409306 200 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 34651066

Group type: EXPERIMENTAL
Intervention: Peer-led, simulator-based training in cardiac physical examination (PE) in addition to standard curricular training
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard curricular training only (Control group)
Number of subjects: 89
Study: 33785465

Group type: EXPERIMENTAL
Intervention: 2 visits at 2 and 6 weeks after delivery
Number of subjects: 250

Group type: COMPARATOR
Intervention: Single 6-week postpartum visit (control)
Number of subjects: 250
Study: 35145071

Group type: EXPERIMENTAL
Intervention: Mass-Fix
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Measurable Residual Disease (MRD)
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Mass-Fix at 1 year
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: MRD at 1 year
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: Mass-Fix pre-induction
Number of subjects: 575

Group type: EXPERIMENTAL
Intervention: SIFE and CR
Number of subjects: 575
Study: 33587126

Group type: EXPERIMENTAL
Intervention: 0.014 × 0.014‐in computer‐aided design/computer‐aided manufacturing nitinol retainer (Memotain)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 0.0215‐in 5‐strand stainless steel wire
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 0.016 × 0.022‐in dead‐soft wire
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Connected bonding pads
Number of subjects: 132
Study: 32157608

Group type: EXPERIMENTAL
Intervention: Early Education and Support (EE-S)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Support and Delayed Education (S-DE)
Number of subjects: 432
Study: 35643218

Group type: EXPERIMENTAL
Intervention: Resin infiltration
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 34753843

Group type: EXPERIMENTAL
Intervention: Mini implants
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Connecticut intrusion arch
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Segmental intrusion arch
Number of subjects: 32
Study: 32296118

Group type: EXPERIMENTAL
Intervention: Synthetic dataset for training instance segmentation neural network
Number of subjects: 0
Study: 35977110

Group type: EXPERIMENTAL
Intervention: 17 W pedaling work rate
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 25 W pedaling work rate
Number of subjects: 96

Group type: COMPARATOR
Intervention: Nonpedaling condition
Number of subjects: 96
Study: 33387976

Group type: EXPERIMENTAL
Intervention: Rise Above (RA), a trauma-informed, e-cigarette preventive intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35119705

Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Number of subjects: 80

Group type: COMPARATOR
Intervention: Liquid nitrogen cryotherapy
Number of subjects: 80
Study: 34865105

Group type: EXPERIMENTAL
Intervention: Mesorectal excision with lateral lymph node dissection
Number of subjects: 663

Group type: COMPARATOR
Intervention: Mesorectal excision alone
Number of subjects: 663
Study: 35475592

Group type: EXPERIMENTAL
Intervention: ITC-rich broccoli sprout extract (BSE) (200 µmol ITC per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33857411

Group type: EXPERIMENTAL
Intervention: Lobaplatin-based induction chemotherapy (lobaplatin 30 mg/m2 on days 1 and 22, fluorouracil 800 mg/m2 on days 1-5 and 22-26 for two cycles) followed by concurrent lobaplatin-based chemoradiotherapy.
Number of subjects: 502

Group type: COMPARATOR
Intervention: Cisplatin-based induction chemotherapy (cisplatin 100 mg/m2 on days 1 and 22, fluorouracil 800 mg/m2 on days 1-5 and 22-26 for two cycles) followed by concurrent cisplatin-based chemoradiotherapy.
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Lobaplatin-based induction chemotherapy (lobaplatin 30 mg/m2) in per-protocol population.
Number of subjects: 502

Group type: COMPARATOR
Intervention: Cisplatin-based induction chemotherapy (cisplatin 100 mg/m2) in per-protocol population.
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Adverse events in lobaplatin group.
Number of subjects: 502

Group type: COMPARATOR
Intervention: Adverse events in cisplatin group.
Number of subjects: 502
Study: 34320702

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: General Anesthesia combined with Epidural Anesthesia (GAEA)
Number of subjects: 128
Study: 32928709

Group type: EXPERIMENTAL
Intervention: Alirocumab 300 mg Q4W
Number of subjects: 803

Group type: EXPERIMENTAL
Intervention: Alirocumab 75 mg Q2W
Number of subjects: 803

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 803
Study: 35834764

Group type: EXPERIMENTAL
Intervention: Combined Personalized Feedback Intervention (PFI)
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Integrated Personalized Feedback Intervention (PFI)
Number of subjects: 269
Study: 32519569

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound group
Number of subjects: 230

Group type: COMPARATOR
Intervention: Clinical examination group
Number of subjects: 230
Study: 36221329

Group type: EXPERIMENTAL
Intervention: Herbal activated carbon smokeless moxibustion
Number of subjects: 88

Group type: COMPARATOR
Intervention: Traditional moxibustion
Number of subjects: 88
Study: 32818573

Group type: EXPERIMENTAL
Intervention: Ashwagandha root extract
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32877471

Group type: EXPERIMENTAL
Intervention: Nursing students in cohort A (+PT)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Nursing students in cohort B (−PT)
Number of subjects: 119
Study: 36385038

Group type: EXPERIMENTAL
Intervention: PCIA with low basal infusion
Number of subjects: 160

Group type: COMPARATOR
Intervention: PCIA with no basal infusion
Number of subjects: 160
Study: 32088665

Group type: EXPERIMENTAL
Intervention: PNMES
Number of subjects: 124

Group type: COMPARATOR
Intervention: Sham PNMES
Number of subjects: 124
Study: 32521133

Group type: EXPERIMENTAL
Intervention: Standard care plus mechanical thrombectomy (thrombectomy group)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard care alone (control group)
Number of subjects: 300
Study: 33759742

Group type: EXPERIMENTAL
Intervention: Cognitive therapy for social anxiety disorder in adolescents (CT‐SAD‐A)
Number of subjects: 12
Study: 35638207

Group type: EXPERIMENTAL
Intervention: BoneMaster coating (PBM group)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Only porous titanium plasma-sprayed coating (P group)
Number of subjects: 53
Study: 34610572

Group type: EXPERIMENTAL
Intervention: ZIKV-Ig (50.0 mL intravenous dose)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 30